- Previous Close
5.95 - Open
6.00 - Bid --
- Ask --
- Day's Range
5.95 - 6.00 - 52 Week Range
2.70 - 6.15 - Volume
1,363 - Avg. Volume
5,900 - Market Cap (intraday)
287.826M - Beta (5Y Monthly) --
- PE Ratio (TTM)
297.50 - EPS (TTM)
0.02 - Earnings Date Mar 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. The company exports its products through a network of distributors and agents in approximately 30 countries. It serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. Amplitude Surgical SA is a subsidiary of Auroralux SAS.
www.amplitude-surgical.comRecent News: AMPLI.PA
View MorePerformance Overview: AMPLI.PA
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMPLI.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMPLI.PA
View MoreValuation Measures
Market Cap
285.43M
Enterprise Value
385.24M
Trailing P/E
262.37
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.63
Price/Book (mrq)
3.01
Enterprise Value/Revenue
3.55
Enterprise Value/EBITDA
15.01
Financial Highlights
Profitability and Income Statement
Profit Margin
1.00%
Return on Assets (ttm)
3.10%
Return on Equity (ttm)
1.15%
Revenue (ttm)
108.47M
Net Income Avi to Common (ttm)
1.09M
Diluted EPS (ttm)
0.02
Balance Sheet and Cash Flow
Total Cash (mrq)
19.78M
Total Debt/Equity (mrq)
126.28%
Levered Free Cash Flow (ttm)
-10.06M